Oral vaccine protects European infants from rotavirus gastroenteritisBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7630.1119 (Published 29 November 2007) Cite this as: BMJ 2007;335:1119
Rotarix is GlaxoSmithKline's oral vaccine against rotavirus infections. It worked well in Latin America, and the company has now completed a large phase III trial in nearly 4000 infants in Europe. Two doses of the vaccine given with other routine vaccinations reduced rotavirus …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial